This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
3 Reasons Why Growth Investors Shouldn't Overlook HireQuest, Inc. (HQI)
by Zacks Equity Research
HireQuest, Inc. (HQI) could produce exceptional returns because of its solid growth attributes.
The Zacks Analyst Blog Highlights Kforce, Cross Country Healthcare, HireQuest and ManpowerGroup
by Zacks Equity Research
Kforce, Cross Country Healthcare, HireQuest and ManpowerGroup are part of the Zacks top Analyst Blog.
Here's Why Momentum in HireQuest, Inc. (HQI) Should Keep going
by Zacks Equity Research
HireQuest, Inc. (HQI) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
4 Staffing Stocks to Watch on Robust January Job Additions
by Ritujay Ghosh
Stocks like Kforce Inc., (KFRC) Cross Country Healthcare, Inc. (CCRN) HireQuest, Inc. (HQI) and ManpowerGroup Inc. (MAN) are likely to benefit from robust job additions to U.S. economy.
The Zacks Analyst Blog Highlights HireQuest, Kforce, ManpowerGroup, Cross Country Healthcare and Robert Half
by Zacks Equity Research
HireQuest, Kforce, ManpowerGroup, Cross Country Healthcare and Robert Half are included in this Analyst Blog.
Blowout Jobs Report a Boon for These 5 Staffing Stocks
by Tirthankar Chakraborty
Invest in staffing stocks like HireQuest (HQI), Kforce (KFRC), ManpowerGroup (MAN), Cross Country Healthcare (CCRN) & Robert Half International (RHI), banking on solid January jobs growth.
Is HireQuest, Inc. (HQI) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
HireQuest, Inc. (HQI) could produce exceptional returns because of its solid growth attributes.
HireQuest, Inc. (HQI) Tops Q3 Earnings Estimates
by Zacks Equity Research
HireQuest, Inc. (HQI) delivered earnings and revenue surprises of 3.45% and 4.48%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Cross Country Healthcare (CCRN) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Cross Country (CCRN) delivered earnings and revenue surprises of 11.46% and 2.94%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Kforce (KFRC) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Kforce (KFRC) delivered earnings and revenue surprises of 1.87% and 1.42%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
New Strong Buy Stocks for October 20th
by Zacks Equity Research
HQI, ABNB, SNEX, HRB and SPXC have been added to the Zacks Rank #1 (Strong Buy) List on October 20, 2022.
New Strong Buy Stocks for October 14th
by Zacks Equity Research
COUP, EE, CHS, HQI and IBA have been added to the Zacks Rank #1 (Strong Buy) List on October 14, 2022.
HireQuest, Inc. (HQI) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
HireQuest, Inc. (HQI) delivered earnings and revenue surprises of 40% and 10.97%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Cross Country Healthcare (CCRN) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Cross Country (CCRN) delivered earnings and revenue surprises of 3.70% and 1.62%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
HireQuest, Inc. (HQI) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
HireQuest, Inc. (HQI) delivered earnings and revenue surprises of 116.67% and 4.42%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?